Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in Acute Decompensated Heart Failure
NCT04049045Phase 2Completed
- Start
- Sep 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of empagliflozin in acute decompensated heart failure (ADHF). Started Sep 2019; status: completed.
02
Drugs
empagliflozin
03
Conditions
acute decompensated heart failure (ADHF)
Beyond the preview
Go deeper on NCT04049045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04049045.